Valuation: Almirall, S.A.

Market Cap 2.51B 2.87B 2.32B 2.15B 4.07B 273B 4.14B 27.77B 10.8B 135B 10.78B 10.55B 465B P/E 2026 *
29.1x
P/E 2027 * 20.7x
Enterprise Value 2.39B 2.74B 2.21B 2.05B 3.88B 260B 3.95B 26.46B 10.29B 128B 10.27B 10.05B 443B EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.67x
Free-Float
35.93%
Yield 2026 *
1.68%
Yield 2027 * 1.84%
1 day+1.74%
1 week+3.91%
Current month+3.91%
1 month+5.60%
3 months-2.99%
6 months-13.84%
Current year-8.88%
1 week 11.12
Extreme 11.12
11.8
1 month 10.92
Extreme 10.92
11.8
Current year 10.82
Extreme 10.82
13.98
1 year 10.06
Extreme 10.06
13.98
3 years 7.74
Extreme 7.74
13.98
5 years 7.16
Extreme 7.16
15.35
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 2022-11-01
Director of Finance/CFO 53 2025-08-30
Chief Tech/Sci/R&D Officer - 2021-07-06
Director TitleAgeSince
Director/Board Member 58 2026-05-07
Director/Board Member - 2015-12-31
Director/Board Member 67 2020-06-30
Date Insider Type Main position Quantity % Market Cap.
23-06-22Buy

Executive/Senior Manager

3,000 0.0017%
23-06-21Buy 4,340 0.0024%
23-06-21Buy

Executive/Senior Manager

6,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+1.74%+3.91%+9.55%+49.52% 2.82B
+2.96%+3.01%+59.87%+173.31% 1,070B
+3.05%+5.23%+72.11%+67.81% 624B
-0.04%+1.20%+35.72%+87.93% 450B
-2.58%-2.07%+27.62%+22.57% 328B
+1.36%+0.17%+29.90%+49.33% 284B
+1.98%+4.08%-25.78%-39.02% 217B
+0.45%+1.65%+25.65%+68.35% 198B
+5.21%+7.93%+21.99%+83.23% 161B
+1.48%-0.04%-4.64%-32.25% 135B
Average +0.95%+2.12%+25.20%+53.08% 347.03B
Weighted average by Cap. +0.29%+2.51%+41.82%+87.31%

Financials

2026 *2027 *
Net sales 1.23B 1.41B 1.13B 1.05B 2B 133B 2.03B 13.6B 5.29B 65.87B 5.28B 5.16B 228B 1.36B 1.56B 1.26B 1.16B 2.21B 148B 2.25B 15.07B 5.86B 72.99B 5.85B 5.72B 252B
Net income 87.24M 99.69M 80.4M 74.52M 141M 9.46B 144M 964M 375M 4.67B 374M 366M 16.14B 122M 140M 113M 104M 198M 13.26B 201M 1.35B 525M 6.54B 525M 513M 22.62B
Net Debt -119M -136M -109M -101M -192M -12.87B -196M -1.31B -510M -6.35B -509M -498M -21.95B -232M -265M -213M -198M -375M -25.11B -382M -2.56B -995M -12.39B -993M -972M -42.84B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,108
Date Price Change Volume
26-07-07 €11.70 +1.74% 141,384
26-07-06 €11.50 +0.88% 111,704
26-07-03 €11.40 -1.55% 99,796
26-07-02 €11.58 +3.21% 126,186
26-07-01 €11.22 -0.36% 120,996
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
11.70EUR
Average target price
14.58EUR
Spread / Average Target
+24.57%

Quarterly revenue - Rate of surprise